(Q42630459)

4 November 2017

title

Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects (English)

1 reference

4 November 2017

1 reference

1 reference

1 reference

S K Swan

1

1 reference

4 November 2017

J V St Peter

series ordinal

2

1 reference

4 November 2017

L J Lambrecht

series ordinal

3

1 reference

4 November 2017

M J Hursting

series ordinal

4

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

4 November 2017

1 reference

4 November 2017

volume

20

1 reference

4 November 2017

issue

7

1 reference

4 November 2017

page(s)

756-770

1 reference

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

Heparin pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

Separation of 21-(R)- and 21-(S)-argatroban: solubility and activity of the individual diastereoisomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

The use of activated clotting times to monitor heparin therapy during and after interventional procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

Argatroban During Percutaneous Transluminal Coronary Angioplasty: Results of a Dose-Verification Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.9.756.35194

10.1592/PHCO.20.9.756.35194

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference